115 MDS-005 STUDY: EFFECT OF BASELINE ENDOGENOUS EPO ON RBC TRANSFUSION INDEPENDENCE (RBC-TI) IN LENALIDOMIDE-TREATED PATIENTS WITH LOW/INTERMEDIATE-1-RISK MDS WITHOUT DEL(5Q). (April 2015) - Santini, V.; Li, J.S.; Swern, A.S.; Almeida, A.; Giagounidis, A.; Fu, T.; Hoenekopp, A.; Beach, C.L.; Skikne, B.; Fenaux, P.